As renal AMLs are relatively genetically simple tumours that are characterised almost exclusively by recurrent TSC2 or TSC1 mutations19, we reasoned that it might be possible to reverse engineer renal AML starting from normal primary cells. This evidence concerns the gene TSC1 and neoplasm.